Home - Boston Life Sciences Times

LATEST ARTICLES

People on the Move

Convergent Therapeutics Appoints Elizabeth L. Montgomery as Chief People Officer

Life Sciences Times - January 28, 20260

Technology

MIT Sloan CIO Symposium Opens Applications for 2026 Innovation Showcase Competition

Life Sciences Times - January 28, 20260

People on the Move

Gensaic Names Nathan Higginson-Scott, PhD, as Chief Research and Development Officer

Life Sciences Times - January 28, 20260

Medtech

FDA Clears RevBio to Launch Pivotal Trial of Cranial Bone Adhesive TETRANITE

Life Sciences Times - January 28, 20260

Pharma

Enzian Pharmaceutics Showcases Gastroretentive Dosage Form That Boosts Bioavailability of Poorly Soluble Drugs

Life Sciences Times - January 28, 20260

Biotech

Qlaris Bio Names Robert Warner to Board of Directors

Life Sciences Times - January 27, 20260

Medtech

Johnson & Johnson Donates $100 Million in MedTech Products Since 2020, Plans Additional $20 Million Investment in 2026

Life Sciences Times - January 27, 20260

Pharma

Independent Analyst Values Vyome’s VT-1953 at Nearly $1 Billion Following Successful Phase 3 Completion

Life Sciences Times - January 27, 20260

People on the Move

BioMed Realty Promotes Three Senior Leaders to Support Long-Term Growth Strategy

Life Sciences Times - January 27, 20260

Life Sciences

Avangrid Foundation Awards $250,000 in Grants to Wildlife Rehabilitation Centers Nationwide

Life Sciences Times - January 27, 20260

1...414243...831 Page 42 of 831

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

May 1, 2026

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

May 1, 2026

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

May 1, 2026

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

May 1, 2026

Most Popular

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

Recent Comments

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

Strand Therapeutics Names Kunal Bhatia Chief Financial Officer

VectorY Therapeutics Cleared to Expand ALS Clinical Trial to Europe and U.K.

Boston Cell Standards Advances Toward FDA Qualification for Cancer Testing Platform

POPULAR CATEGORY

ABOUT US

FOLLOW US